Loading...
| A10250 | Pages: NA | Jul 2022 | 708 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Atp Assays Market
Request Now !ATP Assays Market Outlook – 2027
Variety of enzymatic reactions makes use of ATP which helps in maintain daily life activities. When cells undergo apoptosis and necrosis, a change occurs in the ATP characteristics. This is the reason behind ATP been used on such a broad scale as valid marker of viable cells. ATP are generally measured by firefly luciferase method which is consider to be the most applied method for approximate number of viable cells.
The ATP assay makes use of luciferase which helps in catalyzing the formation of light from D-luciferin and ATP, which is measured with the help of aluminometer or Beta Counter. The main advantage of ATP assay is that the researcher does not have to rely on an incubation step with viable cells population to convert a substrate to a colored compound. Cell culture medium need not be removed or washing the cells before adding the reagent, which can be fully automatic for high throughput.
ATP Assays Marketscope and structure analysis:
Report Metric | Details |
Market size available for years | 2019–2027 |
Base year considered | 2019 |
Forecast period | 2020–2027 |
Forecast units | Value (USD) |
Segments covered | Product, Application, End user, and Region |
Geographies covered | North America (US and Canada), Europe (Germany, UK, France, and the Rest of Europe), Asia Pacific (China, Japan, India, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of LATAM) and The Middle East and Africa |
Companies covered | Major players analyzed includeMerckKGaA, Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Lonza Group, Promega Corporation, Agilent Technologies, Inc., Abcam plc., Danaher Corporation, Hygiena, LLC., and BioThema AB. |
COVID-19 scenario analysis:
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future.
Owing to such factors, COVID 19 is expected to have a significant impact on the ATP Assays market.
Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis:
Constantly rising demand for ATP assays in pharmaceutical and biotechnology companies, there is also a significant increase in pharmaceutical and biotechnology R&D, increasing frequency of cancer, chronic and other infectious diseases and a shift from culture-based tests to rapid tests are the major driving factors of ATP assays market.
Alongside, ATP assaysare also been used to higherthemicrobial contamination testing forthe healthcare sector and the growing applications of ATP assays.
On the other hand, very expensive instruments are the biggest challenge for the marker and are restraining the growth of the ATP assays industry to a certain extent.
New product launches and acquisitions to flourish the market:
On March 12th, 2019, Promega launched the Water-Glo reagent which will be used bioluminescent technology to measure the ATP and additionally monitoring microbial contamination in freshwater, process water, seawater, or wastewater samples can be done using this reagent.
On August 6th, 2018, Hygiena acquired Biomedal’s Food Safety divisionandrenamed it to Hygiena Diagnóstica España which now provides tests for allergen and assays.
On February 16th, 2018, Merck invested around USD 44 million andexpandedtheir manufacturing and distribution centres in India, South Korea, and China.
On August 18th, 2017, Hach which is a subsidiary of Danaher Corporation and this helped them expand in Loveland, US campus by starting a new facility for R&D.
Biotechnology and pharmaceutical companies, hospitals & diagnostic laboratories, food & beverage industry,and academic andresearch institutions are the major consumers of ATP assays. The biotechnology and pharmaceutical companies are the biggestmarket consumers amongst them. Adoption of the ATP assays is very high in biotechnology and pharmaceutical companies is done for the accounts of contamination testing.
Key segments covered:
Segments | Sub-segments |
Product |
|
Application |
|
End User |
|
Regions |
|
Key benefits of the report:
Questions answered in the ATP Assays Market research report:
Key Market Segments
| Segments | Sub-segments |
|---|---|
| By Product |
|
| By Application |
|
| By End User |
|
| By Region |
|
Key Market Players
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
